Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exogenous Sex Hormones and PONV: Evaluating Postoperative Nausea and Vomiting Risk in Transgender Patients

NCT06816355 is registered in ClinicalTrials.gov with Riverside University Health System Medical Center as lead sponsor.

NCT NCT06816355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06816355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exogenous Sex Hormones and PONV: Evaluating Postoperative Nausea and Vomiting Risk in Transgender Patients
Lead sponsor
Riverside University Health System Medical Center
Phase
Observational
Overall status
Completed
Start date
February 4, 2025
Completion date
February 4, 2025
Enrollment
7,348 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative nausea and vomiting, sex hormone, transgender